Switch-hitter: A new strategy to control gene expression relies on a ligand-dependent, ribozyme-based RNA switch. The key feature of this setup is that the ribozyme liberates the ribosome binding site upon cleavage of the message. The design made it possible to screen in vivo for an inducible aptazyme by attaching an aptamer to stem III of the ribozyme, thus preserving naturally occurring stem I/stem II contacts.
No takes yet. Share an insight, caveat, or question.
Wieland et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: